Epidemiology of human mycobacterium bovis disease, California, USA, 2003–2011

Emerging Infectious Diseases

Volumn 21, Issue 3, 2015, Pages 435-443

  Gallivan, Mark ^a   Shah, Neha ^a,b   Flood, Jennifer ^a  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BOVINE TUBERCULOSIS; CHILD; DIABETES MELLITUS; DISEASE SURVEILLANCE; DRUG SENSITIVITY; END STAGE RENAL DISEASE; FEMALE; GENE SEQUENCE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MALE; MIDDLE AGED; MIXED INFECTION; MYCOBACTERIUM BOVIS; NEWBORN; NONHUMAN; ORGAN TRANSPLANTATION; PREDICTIVE VALUE; RETROSPECTIVE STUDY; RISK FACTOR; UNITED STATES; YOUNG ADULT; AGE; DRUG EFFECTS; GENETICS; GENOTYPE; HEALTH SURVEY; INCIDENCE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PRESCHOOL CHILD; TUBERCULOSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTITUBERCULAR AGENTS; CALIFORNIA; CHILD; CHILD, PRESCHOOL; GENOTYPE; HUMANS; INCIDENCE; INFANT; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; TUBERCULOSIS; YOUNG ADULT;

EID: 84923187761     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2103.141539     Document Type: Article

References (33)

1. LoBue PA, Enarson DA, Thoen CO. Tuberculosis in humans and animals: an overview. Int J Tuberc Lung Dis. 2010;14:1075–8.
2. Grange JM. Mycobacterium bovis infection in human beings. Tuberculosis (Edinb). 2001;81:71–7. http://dx.doi.org/10.1054/tube.2000.0263
3. Sunder S, Lanotte P, Godreuil S, Martin C, Boschiroli ML, Besnier JM. Human-to-human transmission of tuberculosis caused by Mycobacterium bovis in immunocompetent patients. J Clin Microbiol. 2009;47:1249–51. http://dx.doi.org/10.1128/JCM.02042-08
4. Yates MD, Grange JM. Incidence and nature of human tuberculosis due to bovine tubercle bacilli in South-East England: 1977–1987. Epidemiol Infect. 1988;101:225–9. http://dx.doi.org/10.1017/S0950268800054133
5. Majoor CJ, Magis-Escurra C, van Ingen J, Boeree MJ, van Soolingen D. Epidemiology of Mycobacterium bovis disease in humans, the Netherlands, 1993-2007. Emerg Infect Dis. 2011;17:457–63. http://dx.doi.org/10.3201/eid1703.101111
6. LoBue PA, Betacourt W, Peter C, Moser KS. Epidemiology of Mycobacterium bovis disease in San Diego County, 1994–2000. Int J Tuberc Lung Dis. 2003;7:180–5.
7. Hlavsa MC, Moonan PK, Cowan LS, Navin TR, Kammerer JS, Morlock GP, et al. Human tuberculosis due to Mycobacterium bovis in the United States, 1995–2005. Clin Infect Dis. 2008;47:168–75. http://dx.doi.org/10.1086/589240
8. Rodwell TC, Moore M, Moser KS, Brodine SK, Strathdee SA. Tuberculosis from Mycobacterium bovis in binational communities, United States. Emerg Infect Dis. 2008;14:909–16. http://dx.doi.org/10.3201/eid1406.071485
9. Dankner WM, Davis CE. Mycobacterium bovis as a signifcant cause of tuberculosis in children residing along the United States–Mexico border in the Baja California region. Pediatrics. 2000;105:E79. http://dx.doi.org/10.1542/peds.105.6.e79
10. Garfein RS, Burgos JL, Rodriquez-Lainz A, Brodine S, Pietrucha A, Rondinelli A, et al. Latent tuberculosis infection in a migrant agricultural community in Baja California, Mexico. J Immigr Minor Health. 2011;13:940–7. http://dx.doi.org/10.1007/s10903-010-9372-2
11. Besser RE, Pakiz B, Schulte JM, Alvarado S, Zell ER, Kenyon TA, et al. Risk factors for positive Mantoux tuberculin skin tests in children in San Diego, California: evidence for boosting and possible foodborne transmission. Pediatrics. 2001;108:305–10. http://dx.doi.org/10.1542/peds.108.2.305
12. Center for Disease Control and Prevention. Human tuberculosis caused by Mycobacterium bovis—New York City, 2001–2004. MMWR Morb Mortal Wkly Rep. 2005;54:605–8.
13. Ramos DF, Tavares L, Almeida da Silva PE. Molecular typing of Mycobacterium bovis isolates: a review. Braz J Microbiol. 2014;45:365–72. http://dx.doi.org/10.1590/S1517-83822014005000045
14. Ohkusa Y, Shigematsu M, Taniguchi K, Okabe N. Notice to readers: new CDC program for rapid genotyping of Mycobac-terium tuberculosis isolates. MMWR Morb Mortal Wkly Rep. 2005;54(Suppl):47–52.
15. Kurbatova EV, Cavanaugh JS, Dalton T, Click S, Cegielski JP. Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999–2009. Clin Infect Dis. 2013;57:1081–93. http://dx.doi.org/10.1093/cid/cit452
16. de Jong BC, Onipede A, Pym AS, Gagneux S, Aga RS, DeRiemer K, et al. Does resistance to pyrazinamide accurately indicate the presence of Mycobacterium bovis? J Clin Microbiol. 2005;43:3530–2. http://dx.doi.org/10.1128/JCM.43.7.3530-3532.2005
17. Park D, Qin H, Jain S, Preziosi M, Minuto JJ, Mathews WC, et al. Tuberculosis due to Mycobacterium bovis in patients coinfected with human immunodefciency virus. Clin Infect Dis. 2010;51:1343–6. http://dx.doi.org/10.1086/657118
18. Majoor CJ, Magis-Escurra C. van IJ, Boeree MJ, van SD. Epidemiology of Mycobacterium bovis disease in humans, the Netherlands, 1993–2007. Emerg Infect Dis. 2011;17:457–63. http://dx.doi.org/10.3201/eid1703.101111
19. LoBue PA, Moser KS. Treatment of Mycobacterium bovis infected tuberculosis patients: San Diego County, California, United States, 1994–2003. Int J Tuberc Lung Dis. 2005;9:333–8.
20. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35:907–14.
21. United States Census Bureau. Population estimates; current estimate data [cited 2014 April 29]. http://www.census.gov/popest/data/index.htm
22. Rodwell TC, Kapasi AJ, Moore M, Milian-Suazo F, Harris B, Guerrero LP, et al. Tracing the origins of Mycobacterium bovis tuberculosis in humans in the USA to cattle in Mexico using spoligotyping. Int J Infect Dis. 2010;14(Suppl 3):e129–35. http://dx.doi.org/10.1016/j.ijid.2009.11.037
23. Kinde H, Mikolon A, Rodriguez-Lainz A, Adams C, Walker RL, Cernek-Hoskins S, et al. Recovery of salmonella, Listeria monocy-togenes, and Mycobacterium bovis from cheese entering the United States through a noncommercial land port of entry. J Food Prot. 2007;70:47–52.
24. Code of Federal Regulations. Title 9—animals and animal products [9 CFR]. Animal and Plant Health Inspection Service, Department of Agriculture. Subchapter D—exportation and importation of animals (including poultry) and animal products. Part 93—importation of certain animals, birds, fsh, and poultry, and certain animal, bird, and poultry products; requirements for means of conveyance and shipping containers [9 CFR 93]. Subpart D— ruminants; Mexico 9, 93.427– 93.429; 2000 Jan 1 [cited 2014 April 29]. http://www.gpo.gov/fdsys/granule/CFR-2000-title9-vol1/CFR-2000-title9-vol1-sec93-427
25. Palmer MV, Waters WR. Bovine tuberculosis and the establishment of an eradication program in the United States: role of veterinarians. Vet Med Int. 2011;2011:816345.
26. Walker TM, Ip CL, Harrel RH, Evans JT, Kapatai G, Dedicoat MJ, et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis. 2013;13:137–46. http://dx.doi.org/10.1016/S1473-3099(12)70277-3
27. de Kantor IN, LoBue PA, Thoen CO. Human tuberculosis caused by Mycobacterium bovis in the United States, Latin America and the Caribbean. Int J Tuberc Lung Dis. 2010;14:1369–73.
28. LoBue PA, LeClair JJ, Moser KS. Contact investigation for cases of pulmonary Mycobacterium bovis. Int J Tuberc Lung Dis. 2004;8:868–72.
29. Lighter J, Rigaud M. Diagnosing childhood tuberculosis: traditional and innovative modalities. Curr Probl Pediatr Adolesc Health Care. 2009;39:61–88. http://dx.doi.org/10.1016/j.cppeds.2008.12.003
30. Andersen P, Doherty TM. The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat Rev Microbiol. 2005;3:656–62. http://dx.doi.org/10.1038/nrmicro1211
31. Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet. 1995;346:1339–45. http://dx.doi.org/10.1016/S0140-6736(95)92348-9
32. García-Rodríguez JF, Álvarez-Díaz H, Lorenzo-García M V, Mariño-Callejo A, Fernandez-Rial Á, Sesma-Sánchez P. Extrapulmonary tuberculosis: epidemiology and risk factors. Enferm Infecc Microbiol Clin. 2011;29:502–9. http://dx.doi.org/10.1016/j.eimc.2011.03.005
33. Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, Burdick E, et al. The effcacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics. 1995;96:29–35.